This Article is From Apr 26, 2021

The International Response To India's Huge Covid Crisis

India is administering an average of about 2.6 million doses per day, according to the Bloomberg Vaccine Tracker. At that pace, it'll take an estimated two years to cover 75% of its population.

Advertisement
India News (c) 2021, Bloomberg

India is administering an average of 2.6 million doses per day, according to Bloomberg Vaccine Tracker

The U.S. will send India raw materials for vaccines and step up financing aid for Covid-19 shot production, joining European countries in pledging help to stem the world's biggest surge in cases.

Material needed to produce Covishield, the Oxford-AstraZeneca vaccine made in India, has been identified and "will immediately be made available," Emily Horne, a spokesperson for U.S. National Security Adviser Jake Sullivan, said in a statement released by the White House.

Sullivan spoke by phone Sunday with his Indian counterpart Ajit Doval, according to the statement, and the pair agreed to stay in close touch.

Additionally, the U.S. Development Finance Corporation will fund an expansion of production capability by Indian vaccine maker Biological E Ltd., or BioE, to at least 1 billion doses by the end of 2022. Ventilators, therapeutics, rapid-test kits and personal protective equipment will be sent as well, according to the statement.

The U.K., France and Germany also pledged aid for India, which has reported some 1 million new cases over the last three days and 2,767 deaths in the latest 24-hour period. The outbreak is increasingly closing the rest of the world to travelers from India and threatening the country's economic recovery.

Advertisement

India is administering an average of about 2.6 million doses per day, according to the Bloomberg Vaccine Tracker. At that pace, it'll take an estimated two years to cover 75% of its population.

Earlier, President Joe Biden's chief medical adviser said the U.S. will consider sending India stockpiled doses of AstraZeneca Plc's vaccine currently unapproved for use in the U.S.

Advertisement

"I think that's going to be something that is up for active consideration," Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said Sunday on ABC's "This Week," while cautioning that he didn't "want to be speaking for policy right now."

The U.S. stockpile of AstraZeneca shots reached more than 20 million doses earlier this month and has grown since then, prompting persistent calls by doctors and others to donate the shots to other countries that are way behind the U.S. in their vaccination efforts. That's gained urgency with India's worsening crisis.

Advertisement

AstraZeneca hasn't requested regulatory approval for its two-dose vaccine in the U.S., which has three other authorized vaccines to deploy. Biden by March had ordered almost enough Covid-19 vaccines to fully inoculate every American adult twice.

India is also a producer of the AstraZeneca vaccine, which it's been exporting.

Advertisement

The U.K. is sending nine airline containers of supplies, including oxygen concentrators and ventilators from surplus stocks, that will begin arriving in New Delhi on Tuesday, the Foreign Office in London said in a statement.

Prime Minister Boris Johnson said the U.K. "will continue to work closely with the Indian government during this difficult time," according to the statement.

Advertisement

Additionally, France will supply India "with significant support in terms of oxygen," President Emmanuel Macron's office told Agence France-Presse. France plans to ship respirators, AFP reported. Chancellor Angela Merkel said Germany is "urgently preparing a mission of support," her chief spokesman said on Twitter.

Secretary of State Antony Blinken said late Saturday that the U.S. is working with India's government amid the "horrific" outbreak.

The U.S. "will rapidly deploy additional support to the people of India and India's health care heroes," he said on Twitter.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Advertisement